BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Munoz-Pinto MF, Empadinhas N, Cardoso SM. The neuromicrobiology of Parkinson's disease: A unifying theory. Ageing Res Rev 2021;70:101396. [PMID: 34171417 DOI: 10.1016/j.arr.2021.101396] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Naren P, Cholkar A, Kamble S, Samim KS, Srivastava S, Madan J, Mehra N, Tiwari V, Singh SB, Khatri DK. Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay. JAD 2022. [DOI: 10.3233/jad-220682] [Reference Citation Analysis]
2 Costa HN, Esteves AR, Empadinhas N, Cardoso SM. Parkinson's Disease: A Multisystem Disorder. Neurosci Bull 2022. [PMID: 35994167 DOI: 10.1007/s12264-022-00934-6] [Reference Citation Analysis]
3 Bairamian D, Sha S, Rolhion N, Sokol H, Dorothée G, Lemere CA, Krantic S. Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease. Mol Neurodegeneration 2022;17. [DOI: 10.1186/s13024-022-00522-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
4 Kramer P. Mitochondria-Microbiota Interaction in Neurodegeneration. Front Aging Neurosci 2021;13:776936. [PMID: 35002678 DOI: 10.3389/fnagi.2021.776936] [Reference Citation Analysis]
5 Danilenko V, Devyatkin A, Marsova M, Shibilova M, Ilyasov R, Shmyrev V. Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention. J Inflamm Res 2021;14:6349-81. [PMID: 34876830 DOI: 10.2147/JIR.S333887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Esteves AR, Munoz-Pinto MF, Nunes-Costa D, Candeias E, Silva DF, Magalhães JD, Pereira-Santos AR, Ferreira IL, Alarico S, Tiago I, Empadinhas N, Cardoso SM. Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria. Gut 2021:gutjnl-2021-326023. [PMID: 34836918 DOI: 10.1136/gutjnl-2021-326023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Leite AOF, Bento Torres Neto J, Dos Reis RR, Sobral LL, de Souza ACP, Trévia N, de Oliveira RB, Lins NAA, Diniz DG, Diniz JAP, Vasconcelos PFDC, Anthony DC, Brites D, Picanço Diniz CW. Unwanted Exacerbation of the Immune Response in Neurodegenerative Disease: A Time to Review the Impact. Front Cell Neurosci 2021;15:749595. [PMID: 34744633 DOI: 10.3389/fncel.2021.749595] [Reference Citation Analysis]
8 Galano A, Guzmán-López EG, Reiter RJ. Potentiating the Benefits of Melatonin through Chemical Functionalization: Possible Impact on Multifactorial Neurodegenerative Disorders. Int J Mol Sci 2021;22:11584. [PMID: 34769013 DOI: 10.3390/ijms222111584] [Reference Citation Analysis]
9 Franco R, Casanovas B, Camps J, Navarro G, Martínez-Pinilla E. Antixoxidant Supplements versus Health Benefits of Brief/Intermittent Exposure to Potentially Toxic Physical or Chemical Agents. Curr Issues Mol Biol 2021;43:650-64. [PMID: 34287292 DOI: 10.3390/cimb43020047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]